Technology

Cheetah Medical announced that it is now offering the U.S. Food and Drug Administration (FDA)-cleared and CE-marked Starling SV hemodynamic monitoring system. The noninvasive system provides data for real-time clinical decision-making and optimized patient outcomes across a hospital’s continuum of care.

Home June 26, 2015
Home
MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue
Feature | Contrast Media

New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients annually, according to a new paper. The paper was published online by the journal Investigative Radiology, which is published by Wolters Kluwer.

Home June 26, 2015
Home
News | Cardiovascular Business

The United States Supreme Court voted to uphold the nationwide tax subsidies provided by the Affordable Care Act (ACA) in a 6-3 ruling on Thursday in the case of King v. Burwell.

Home June 25, 2015
Home
Feature | Cardiovascular Ultrasound

A nationwide study published in the Journal of the American College of Cardiology identified current frequent barriers to cardio-oncology services in the United States. According to the study, many hospital training programs have no formal training or services in cardio-oncology, and a lack of national guidelines and funding also creates barriers.

Home June 24, 2015
Home
fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord
Feature | Heart Failure

To date, the only definitive treatment for heart failure — an organ transplant — is hampered by both the limited number of organ donors and the potential for the patient's body to reject the new heart. However, findings of a study published in STEM CELLS: Translational Medicine demonstrate the promise in regenerating cardiac tissue using engineered patches made up of a mixture of fibrin and mesenchymal stem cells (MSCs) derived from human umbilical cord blood.

Home June 24, 2015
Home
News | Heart Failure

Scott & White Memorial — Temple for the first time implanted a new miniaturized, wireless monitoring sensor to help manage heart failure (HF). Scott & White Memorial is one of six hospitals in Texas and the first hospital in the Baylor Scott & White Health system to offer the device.

Home June 24, 2015
Home
News | Advanced Visualization

Texas Children's Hospital successfully separated Knatalye Hope and Adeline Faith Mata in late February, completing one of the most complex conjoined twins separations ever. The procedure took months of planning, and Toshiba's Aquilion ONE CT system played a crucial role in determining the feasibility of separating the twins and producing images that helped radiologists build detailed 3-D models of the organs.

Home June 24, 2015
Home
Technology | Point-of-Care Ultrasound (POCUS)

Philips announced the introduction of Lumify, its first app-based ultrasound solution that will extend the reach of ultrasound applications across the health continuum using mobile technology. The technology was unveiled at the Social Media and Critical Care (SMACC) conference, June 23-26, in Chicago.

Home June 24, 2015
Home
News | Embolic Protection Devices

InspireMD Inc. announced that its CGuard embolic prevention system reported positive results in the PARADIGM study at the EuroPCR conference, May 22 in Paris. The study was lead by principle investigator Prof. Piotr Musialek.

Home June 23, 2015
Home
News | Pacemakers

Results from a clinical trial evaluating the Micra transcatheter pacing system (TPS), the world’s smallest pacemaker, were presented at the Heart Rhythm Society’s 36th annual scientific sessions in May. The device was shown to meet its initial safety and performance measures, as 100 percent of the first 140 patients who received it experienced a successful implant procedure. The study was conducted at the Minneapolis Heart Institute Foundation.

Home June 23, 2015
Home
defibrillators, older heart patients, Duke Medicine study, Tracy Wang
Feature | Implantable Cardioverter Defibrillator (ICD)

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association. But fewer than 1 in 10 eligible patients actually get a defibrillator within a year of their heart attacks, the study found.

Home June 23, 2015
Home
Technology

Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the recapturable, self-expanding CoreValve Evolut R System. The first-and-only recapturable and repositionable device available in the United States, the Evolut R System is approved for transcatheter aortic valve replacement (TAVR) in severe aortic stenosis patients who are at high or extreme risk for surgery. Untreated, aortic valve stenosis can lead to serious heart problems including heart failure and even death.

Home June 23, 2015
Home
News | Remote Monitoring

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) may be underestimating device problems, according to UC San Francisco researchers. They propose systematic methods to determine accurate causes of sudden death in those with CIEDs such as defibrillators and pacemakers, as well as improved monitoring for device concerns.

Home June 22, 2015
Home
Technology

The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary intervention (PCI). The novel, intravenous antiplatelet agent is indicated for reducing periprocedural thrombotic events in patients who have not been treated with a P2Y12 inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor (GPI).

Home June 22, 2015
Home
News | Cardiovascular Ultrasound

The American Society of Echocardiography (ASE) and Ke Labs jointly announced in May an agreement to co-develop and co-market a new cardiac ultrasound software application. The application is designed to ensure quality and consistency of cardiac ultrasound image review — both quantitatively and qualitatively — and inform and educate users on interesting cases, new techniques and other changes. This medical imaging quality management software tool is generally referred to as the “Echocardiography Test and Teach Application,” and it has been designed through the expert guidance of Harvey Feigenbaum, M.D., FASE with the Krannert Institute of Cardiology at Indiana University Health and founder of the ASE.

Home June 22, 2015
Home
Subscribe Now